Methylphenidate on SilverScript Choice (S5601-022)
Covered.
Tier 3 (preferred brand). Quantity limit of 90 per 30 days.
$5.96
Patient pays / month, after deductible
$33.09
Patient pays / month, before the $615.00 deductible
$17.87
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
METHYLPHENIDATE HYDROCHLORIDE 20 mg Tablet at a preferred retail pharmacy, from the plan's negotiated price of $33.09 for a month. Other covered strengths are listed below.
All 8 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| METHYLPHENIDATE HYDROCHLORIDE 10 mg Tablet | 3 | $6.58 | 90 per 30 days |
| METHYLPHENIDATE HYDROCHLORIDE 10 mg Tablet, Extended Release | 4 | $13.56 | 90 per 30 days |
| METHYLPHENIDATE HYDROCHLORIDE 20 mg Capsule, Extended Release | 4 | $90.19 | 30 per 30 days |
| METHYLPHENIDATE HYDROCHLORIDE 20 mg Tablet | 3 | $5.96 | 90 per 30 days |
| METHYLPHENIDATE HYDROCHLORIDE 20 mg Tablet, Extended Release | 4 | $31.84 | 90 per 30 days |
| METHYLPHENIDATE HYDROCHLORIDE 30 mg Capsule, Extended Release | 4 | $148.29 | 60 per 30 days |
| METHYLPHENIDATE HYDROCHLORIDE 40 mg Capsule, Extended Release | 4 | $17.86 | 30 per 30 days |
| METHYLPHENIDATE HYDROCHLORIDE 5 mg Tablet | 3 | $6.49 | 90 per 30 days |
Verify with the plan before prescribing or filling. Member services: (866)235-5660. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5601-022